TrialThe Lancet. Neurology2025

Safety and efficacy of atorvastatin for rebleeding in cerebral cavernous malformations (AT CASH EPOC): a phase 1/2a, randomised placebo-controlled trial.

Issam A Awad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.